The risk of venous thromboembolism associated with peripherally inserted central catheters in ambulant cancer patients

Thrombosis Journal

Volumn 15, Issue 1, 2017, Pages

  Jones, Daniel ^a,b,c   Wismayer, Kurt ^a   Bozas, George ^a   Palmer, June ^a   Elliott, Mandi ^a   Maraveyas, Anthony ^a,b  

^a CASTLE HILL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF HULL   (United Kingdom)

^c UNIVERSITY OF HULL   (United Kingdom)

Author keywords

Anticoagulation; Cancer; Deep Vein Thrombosis; Peripherally Inserted Central Catheters; Risk Factors; Venous Thromboembolism

Indexed keywords

FLUOROPYRIMIDINE;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CARDIOVASCULAR RISK; CENTRAL VENOUS CATHETERIZATION; CLINICAL AUDIT; COHORT ANALYSIS; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN CELL; INCIDENCE; LEUKOCYTE COUNT; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASM; MEDICAL RECORD; MIDDLE AGED; PATIENT REFERRAL; PERIPHERALLY INSERTED CENTRAL VENOUS CATHETER; RETROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; SURVIVAL RATE; VENOUS THROMBOEMBOLISM;

EID: 85029611424     PISSN: None     EISSN: 14779560     Source Type: Journal    
DOI: 10.1186/s12959-017-0148-y     Document Type: Article

References (32)

1. Aw A, et al. Incidence and predictive factors of symptomatic thrombosis related to peripherally inserted central catheters in chemotherapy patients. Thromb Res. 2012;130(3):323-6.
2. Verso M, Agnelli G. Venous thromboembolism associated with long-term use of central venous catheters in cancer patients. J Clin Oncol. 2003;21(19):3665-75.
3. Chopra V, et al. Risk of venous thromboembolism associated with peripherally inserted central catheters: a systematic review and meta-analysis. Lancet. 2013;382(9889):311-25.
4. Liem TK, et al. Peripherally inserted central catheter usage patterns and associated symptomatic upper extremity venous thrombosis. J Vasc Surg. 2012;55(3):761-7.
5. Meyer BM. Developing an alternative workflow model for peripherally inserted central catheter placement. J Infus Nurs. 2012;35(1):34-42.
6. Sperry BW, Roskos M, Oskoui R. The effect of laterality on venous thromboembolism formation after peripherally inserted central catheter placement. J Vasc Access. 2012;13(1):91-5.
7. Evans RS, et al. Risk of symptomatic DVT associated with peripherally inserted central catheters. Chest. 2010;138(4):803-10.
8. Winters JP, et al. Central venous catheters and upper extremity deep vein thrombosis in medical inpatients: the Medical Inpatients and Thrombosis (MITH) Study. J Thromb Haemost. 2015;13(12):2155-60.
9. Fallouh N, et al. Peripherally Inserted Central Catheter-associated Deep Vein Thrombosis: A Narrative Review. Am J Med. 2015;128(7):722-38.
10. Shivakumar SP, Anderson DR, Couban S. Catheter-associated thrombosis in patients with malignancy. J Clin Oncol. 2009;27(29):4858-64.
11. Kuter DJ. Thrombotic complications of central venous catheters in cancer patients. Oncologist. 2004;9(2):207-16.
12. Saber W, et al. Risk factors for catheter-related thrombosis (CRT) in cancer patients: a patient-level data (IPD) meta-analysis of clinical trials and prospective studies. J Thromb Haemost. 2011;9(2):312-9.
13. Lee AY, et al. Incidence, risk factors, and outcomes of catheter-related thrombosis in adult patients with cancer. J Clin Oncol. 2006;24(9):1404-8.
14. Grove JR, Pevec WC. Venous thrombosis related to peripherally inserted central catheters. J Vasc Interv Radiol. 2000;11(7):837-40.
15. Evans RS, et al. Reduction of peripherally inserted central catheter-associated DVT. Chest. 2013;143(3):627-33.
16. Cotogni P, Pittiruti M. Focus on peripherally inserted central catheters in critically ill patients. World J Crit Care Med. 2014;3(4):80-94.
17. Stein PD, et al. Incidence of venous thromboembolism in patients hospitalized with cancer. Am J Med. 2006;119(1):60-8.
18. Kearon C, et al. Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report. Chest. 2016;149(2):315-52.
19. Karthaus M, et al. Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trial. Ann Oncol. 2006;17(2):289-96.
20. Young AM, et al. Warfarin thromboprophylaxis in cancer patients with central venous catheters (WARP): an open-label randomised trial. Lancet. 2009;373(9663):567-74.
21. Akl EA, et al. Anticoagulation for people with cancer and central venous catheters. Cochrane Database Syst Rev. 2014;10:CD006468.
22. Loughran SC, Borzatta M. Peripherally inserted central catheters: a report of 2506 catheter days. JPEN J Parenter Enteral Nutr. 1995;19(2):133-6.
23. Starling N, et al. Thromboembolism in patients with advanced gastroesophageal cancer treated with anthracycline, platinum, and fluoropyrimidine combination chemotherapy: a report from the UK National Cancer Research Institute Upper Gastrointestinal Clinical Studies Group. J Clin Oncol. 2009;27(23):3786-93.
24. Zapponi KC, et al. Increased adhesive properties of neutrophils and inflammatory markers in venous thromboembolism patients with residual vein occlusion and high D-dimer levels. Thromb Res. 2014;133(5):736-42.
25. Blom JW, et al. Incidence of venous thrombosis in a large cohort of 66,329 cancer patients: results of a record linkage study. J Thromb Haemost. 2006;4(3):529-35.
26. Polk A, et al. A systematic review of the pathophysiology of 5-fluorouracil-induced cardiotoxicity. BMC Pharmacol Toxicol. 2014;15:47.
27. Sriskandarajah P, et al. Retrospective cohort analysis comparing the incidence of deep vein thromboses between peripherally-inserted and long-term skin tunneled venous catheters in hemato-oncology patients. Thromb J. 2015;13:21.
28. Nifong TP, McDevitt TJ. The effect of catheter to vein ratio on blood flow rates in a simulated model of peripherally inserted central venous catheters. Chest. 2011;140(1):48-53.
29. Chopra V, et al. The Michigan Appropriateness Guide for Intravenous Catheters (MAGIC): Results From a Multispecialty Panel Using the RAND/UCLA Appropriateness Method. Ann Intern Med. 2015;163(6 Suppl):S1-40.
30. Sharp R, et al. The catheter to vein ratio and rates of symptomatic venous thromboembolism in patients with a peripherally inserted central catheter (PICC): a prospective cohort study. Int J Nurs Stud. 2015;52(3):677-85.
31. Greene MT, et al. The Association Between PICC Use and Venous Thromboembolism in Upper and Lower Extremities. Am J Med. 2015;128(9):986-93. e1
32. Chopra V, et al. Peripherally inserted central catheter-related deep vein thrombosis: contemporary patterns and predictors. J Thromb Haemost. 2014;12(6):847-54.